COVID-19: progression of disease and intravascular coagulation – present status and future perspectives
Job Harenberg, Emmanuel J. Favaloro
Abstract
The timely and accurate diagnosis of infection with severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), remains the cornerstone of efforts to provide appropriated treatment for patients, to limit further spread of the virus and ultimately to eliminate the virus from the human society. We focus this article on (a) developments for improvement of diagnosis of specific SARS-CoV-2 virus, (b) laboratory changes in the immunologic and coagulation system, (c) therapeutic options for anticoagulant treatment of seriously affected patients and (d) on the perspectives through improvement of diagnostic and therapeutic medical procedures.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Disseminated intravascular coagulation2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineDiseasePandemicIntensive care medicineCoagulationBetacoronavirusCoronavirus InfectionsPathologyVirologyInternal medicineInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsLong-Term Effects of COVID-19